BioVenture Consultants' expertise lies in the assessment of emerging bioscience technologies. The firm provides technical, market, and clinical insights, as well as financial analysis for corporations and the financial community. Our services range from the creation and evaluation of business plans, to analysis of competing technologies and companies, product market opportunities, corporate partnering, and strategic issues.

BioVenture Consultants provides unparalleled resources and cost-effective support in strategic planning and business development. By combining strong technical experience with a proven track record in market and technology analysis, BioVenture Consultants provides services tailored to the needs of an individual client on both project and retained-fee bases.

The firm's two principals, Cynthia Robbins-Roth, Ph.D. and Carol Hall, Ph.D./CFA, have provided advisory services to the biopharma industry since 1986 as consultants, and served on Boards of Directors and Scientific Advisory Boards. Their clients have included venture firms, established and early-stage biotech and biopharma companies, and international economic development agencies.

Dr. Robbins-Roth is a frequent speaker on the industry and writes a column for BioWorld Today. You may read her columns here.